Attached files
file | filename |
---|---|
8-K - FORM 8-K FOR 02-18-2011 - Lotus Pharmaceuticals, Inc. | form_8-k.htm |
Exhibit 3.1
AMENDMENT TO THE BYLAWS
OF
Lotus Pharmaceuticals, Inc.
(a Nevada corporation)
February 18, 2011
The Bylaws of Lotus Pharmaceuticals, Inc., a Nevada corporation, are hereby amended as follows:
Article VI, Section 5 shall be deleted in its entirety and replaced by the following which shall be inserted in lieu thereof:
Section 5. The stock transfer book may not be closed for any purpose. The Board of Directors may fix in advance a date as the record date for the purpose of determining shareholders entitled to notice of or to vote at any meeting of shareholders or any adjournment thereof, or entitled to receive a distribution by the corporation (other than a distribution involving a purchase or redemption by the corporation of any of its own shares) or a share dividend, or in order to make a determination of shareholders for any other proper purpose, such date in any case to be not more than sixty (60) days, and, in the case of a meeting of shareholders, not less than ten (10) days, prior to the date on which the particular action requiring such determination of shareholders is to be taken. If no record date is fixed for the determination of shareholders entitled to notice of or to vote at a meeting of shareholders, or shareholders entitled to receive a distribution (other than a distribution involving a purchase or redemption by the corporation of any of its own shares) or a share dividend, the date on which notice of the meeting is mailed or the date on which the resolution of the Board of Directors declaring such distribution or share dividend is adopted, as the case may be, shall be the record date for such determination of shareholders. When a determination of shareholders entitled to vote at any meeting of shareholders has been made as provided in this Section, such determination shall apply to any adjournment thereof.
This Amendment was adopted in accordance with the Bylaws of Lotus Pharmaceuticals, Inc. on February 18, 2011.
APPROVED: | /s/ Liu Zhongyi |